to BioTechniques free email alert service to receive content updates.

POSTER
Detection of Prostate Cancer BioMarkers by Expression Microarray Analysis of TransPlex® WTA2 Amplified FFPE Tissue RNA
Ken Heuerman and Brian Ward
Sigma Life Science
Sponsored by Sigma-Aldrich
Published in December 2010 2010 (p.9) DOI:  10.2144/000113594 Sponsored,vendor-submitted protocol
The Transplex® Complete Whole Transcriptome Amplification (WTA2) Kit has been enhanced to effectively amplify damaged RNA and low input amounts of RNA.Total RNA samples isolated from matched FFPE(formalin-fixedparaffin-embedded) and frozen prostate tissues (malignant and normal) were amplified with the Transplex® Complete WTA2 Kit and analyzed on Agilent Whole Genome expression microarrays. A call rate of >65% was observed for combined FFPE and frozen expression differentials (Malignant/Normal), with >90% commonality between the FFPE and frozen datasets. Amplification reproducibility of experimental replicates was demonstrated by principal component analysis.Pair-wise comparison of FFPE malignant and normal expression(p<0.0001) resulted in detection of 66 known prostate cancer biomarkers. Similar microarray pair-wise analysis of the original matched FFPE RNAs amplified with the Nugen WT-Ovation™FFPE Kit at significantly lower level of confidence(p<0.05) revealed only a single array feature, disallowing a comprehensive comparison with Transplex WTA2.These results confirm the utility of the Transplex WTA2Kit for amplification of damaged DNA.
More Information
Do you have question about this Poster? Would you like more information about this poster?
Submit your questions here and BioTechniques will forward your question and contact information from our database to an expert at Sigma-Aldrich
Request more information
Yes, please forward my question, along with my name, title, company, and e-mail address to Sigma-Aldrich
BioTechniques will forward your question to the company, who will contact you directly by email.
 
Name Question
Job Title
Company
Email
Contact Information